Department of Pediatric Surgery and Urology, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, France.
Paris Descartes University, Université Sorbonne Paris Cité, Paris, France.
Pediatr Blood Cancer. 2019 Aug;66 Suppl 3:e27670. doi: 10.1002/pbc.27670. Epub 2019 Mar 4.
Prognosis of dumbbell neuroblastoma (NBL) is mainly determined by the sequelae induced by the tumor itself and the neurosurgical approach. However, after primary chemotherapy, surgical management of the residual tumor, especially the spinal canal component, remains controversial.
We conducted a single-center retrospective cohort study over the last 15 years (2002-2017) including patients treated for NBL with spinal canal extension focusing on timing and type of surgery, complications, and functional and oncological follow-up.
Thirty-two children (14 M, 18 F) were managed for NBL, with the majority (26) presenting with NBL stroma poor while four had ganglioneuroblastoma intermixed, one nodular, and one ganglioneuroma. All but two patients received neoadjuvant chemotherapy. Upfront laminotomy for spinal cord decompression was performed in two patients; nine patients had extraspinal surgery with a follow-up neurosurgical procedure in seven cases; eight patients had initial neurosurgery followed by an extraspinal procedure, while six patients underwent a combined multidisciplinary approach. With a median follow up of 3.6 years (0.1-14.9), 29 patients (90.6) are alive and two out of three (19, 65.5%) have functional sequelae.
Patients with NBL with persistent spinal canal extension of the tumor after neoadjuvant chemotherapy treated at our center had outcomes that compare favorably with the literature. This is likely due to the multidisciplinary approach to optimal surgical strategy and continuous evaluation of the respective risks of tumor progression. Neurological disability results from initial spinal cord compression or the radicular sacrifice required for tumor resection.
哑铃型神经母细胞瘤(NBL)的预后主要取决于肿瘤本身及其神经外科手术所引起的后遗症。然而,在初次化疗后,对于残余肿瘤的手术处理,尤其是椎管内部分,仍存在争议。
我们进行了一项单中心回顾性队列研究,时间跨度为过去 15 年(2002-2017 年),包括因椎管内延伸的 NBL 而接受治疗的患者,重点关注手术时机和类型、并发症以及功能和肿瘤学随访。
32 名儿童(14 名男性,18 名女性)接受了 NBL 治疗,其中大多数(26 名)为 NBL 基质不良,4 名患者混合有神经节母细胞瘤,1 名呈结节状,1 名神经节细胞瘤。除两名患者外,所有患者均接受了新辅助化疗。两名患者接受了 upfront 椎板切开术以进行脊髓减压;9 名患者接受了椎管外手术,其中 7 例患者进行了后续神经外科手术;8 名患者先接受了神经外科手术,然后进行了椎管外手术,而 6 名患者则采用了联合多学科的方法。在中位数为 3.6 年(0.1-14.9 年)的随访中,29 名患者(90.6%)存活,其中 3 名中有 2 名(19%,65.5%)存在功能后遗症。
在我们中心接受治疗的接受新辅助化疗后肿瘤仍有持续性椎管内延伸的 NBL 患者的结果与文献相比表现良好。这可能是由于采取了多学科方法来制定最佳手术策略,并持续评估肿瘤进展的各自风险。神经功能障碍是由初始脊髓压迫或肿瘤切除所需的神经根牺牲引起的。